Buying Dividends: Next Week's Ex-Div Stocks [View article]
do you cover special dividends such as TDG ? TransDigm OKs special dividend of $7.65 per share TransDigm group approves one-time dividend of $7.65 per share, completion of debt offering
CLEVELAND (AP) -- TransDigm Group Inc., which makes aircraft components, said Tuesday its board of directors authorized a one-time cash dividend of $7.65 per share of common stock.
On June 23, 2009, the Pediatric Advisory Committee will review and discuss reports by the Agency, as mandated by the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, for Alvesco (ciclesonide), Androgel (testosterone), Asmanex (mometasone furoate), Combigan (brimonidine/timolol), Depakote (divalproex sodium), Derma-Smoothe F/S (fluocinolone acetate), Diovan (valsartan), Hepsera (adefovir dipivoxil), Inspra (eplerenone), Moxatag (amoxicillin), Omnaris (ciclesonide), and Zometa (zoledronic acid).
More complete information about the topics on which FDA will seek public input will be available by or around June 19, 2009 at www.fda.gov/AdvisoryCo..., click on the year 2009 and scroll down to the appropriate advisory committee link.
Sort by:
Latest | Highest ratedBuying Dividends: Next Week's Ex-Div Stocks [View article]
TransDigm OKs special dividend of $7.65 per share
TransDigm group approves one-time dividend of $7.65 per share, completion of debt offering
CLEVELAND (AP) -- TransDigm Group Inc., which makes aircraft components, said Tuesday its board of directors authorized a one-time cash dividend of $7.65 per share of common stock.
Feuerstein Comments on Antigenics: Weak at Best [View article]
Amgen's Better than Expected Portfolio Outlook [View article]
do you have names of company having products reviewing by FDA
www.fda.gov/AdvisoryCo...
On June 23, 2009, the Pediatric Advisory Committee will review and discuss reports by the Agency, as mandated by the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, for Alvesco (ciclesonide), Androgel (testosterone), Asmanex (mometasone furoate), Combigan (brimonidine/timolol), Depakote (divalproex sodium), Derma-Smoothe F/S (fluocinolone acetate), Diovan (valsartan), Hepsera (adefovir dipivoxil), Inspra (eplerenone), Moxatag (amoxicillin), Omnaris (ciclesonide), and Zometa (zoledronic acid).
More complete information about the topics on which FDA will seek public input will be available by or around June 19, 2009 at www.fda.gov/AdvisoryCo..., click on the year 2009 and scroll down to the appropriate advisory committee link.
thanks
Goldman and iShares To Launch Natural Gas ETF [View article]